DTIL · Precision Biosciences Inc
United States · RS rating 28 · As of 2026-10-14
| Price | 6.03 USD |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 26 / 13 / 58 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 39 / 33 / 54 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +157.1% |
| Sales growth Q/Q | +263007.7% |
| Distance from 52-week high | +35.0% |
| Market cap (USD) | $188.6M |